Related Experiment Video
Updated: Nov 10, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Emerging Trends in Cancer Drug Discovery-From Drugging the "Undruggable" to Overcoming Resistance
Joachim Rudolph1, Jeff Settleman2, Shiva Malek3
1Genentech Research and Early Development, South San Francisco, California.
Abstract:
Technology advancement and the courage to challenge dogma have been key elements that have continuously shifted druggability limits. We illustrate this notion with several recent cancer drug-discovery examples, while also giving an outlook on the opportunities offered by newer modalities such as chemically induced proximity and direct targeting of RNA. Treatment resistance is a major impediment to the goal of durable efficacy and cure, but the confluence of new biological insights, novel drug modalities, and drug combinations is predicted to enable transformative progress in this decade and beyond.
Insights
Technological advances and novel drug strategies are expanding cancer treatment possibilities. New approaches like chemically induced proximity and RNA targeting promise to overcome treatment resistance for better patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Cancer drug discovery continuously evolves, pushing the boundaries of what is considered druggable.
- Treatment resistance remains a significant obstacle to achieving long-term cure and efficacy in cancer patients.
Purpose of the Study:
- To illustrate how technological advancements and challenging established dogmas have expanded cancer drug discovery.
- To provide an outlook on emerging therapeutic modalities and their potential impact on overcoming treatment resistance.
Main Methods:
- Review of recent cancer drug-discovery examples.
- Exploration of novel therapeutic modalities, including chemically induced proximity and direct RNA targeting.
- Analysis of the role of biological insights and drug combinations in advancing cancer therapy.
Main Results:
- Demonstration of how innovation has shifted druggability limits in cancer treatment.
- Identification of promising new drug modalities with the potential to address unmet needs.
- Highlighting the convergence of biology, modalities, and combinations for future progress.
Conclusions:
- Technological innovation and challenging dogma are crucial drivers in cancer drug discovery.
- Emerging modalities like chemically induced proximity and RNA targeting offer new avenues for treatment.
- A combination of biological insights, novel drugs, and combination therapies is expected to revolutionize cancer care in the coming decade.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...